|
(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: no further information can be obtained the following information was requested, but unavailable: did the "thread unraveling from needle" occur during use on the patient or upon handling/before use on the patient? were there any patient consequences? how was the procedure completed? if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Product complaint # (b)(4) date sent to the fda: 11/16/2021 additional information: d4, h4, h6 a manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested and the following was obtained: "during the months of (b)(6) 2021 there were several incidents associated with the violet prolene 0 and vicryl 3-0 sutures, with reports from different physicians indicating that the needle is loosening from the thread (pull off).For the prolene 0 suture, about 10 surgical procedures were reported and for the violet 3-0 vicryl suture, about 5 procedures, the exact number is unknown.Vicryl 3-0 events are associated with 4 different surgeons but it is unclear how many complaints each reported.There were no adverse events associated with these events.The doctors only had difficulties to find the needle, but in the end it was possible to remove it." this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The following medwatches have been submitted to capture events: events related to vicryl suture has been submitted via mw # mwr-25102021-0001066214, mwr-25102021-0001066222, mwr-25102021-0001066235, mwr-26102021-0001066337, and mwr-09082021-0001014644.Events related to prolene suture has been submitted via mw # mwr-25102021-0001066170, mwr-25102021-0001066195, mwr-26102021-0001066330, mwr-25102021-0001066326, mwr-25102021-0001066020, mwr-25102021-0001066265, mwr-25102021-0001066040, mwr-25102021-0001066059, mwr-25102021-0001066318, and mwr-26102021-0001067188.
|